US Stock MarketDetailed Quotes

RANI Rani Therapeutics

Watchlist
  • 2.080
  • +0.040+1.96%
Close Nov 22 16:00 ET
  • 2.100
  • +0.020+0.96%
Post 20:01 ET
69.29MMarket Cap-1980P/E (TTM)

Rani Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
41.20%-8.41M
26.60%-9.03M
22.64%-9.4M
-10.15%-51.24M
14.70%-12.48M
-17.26%-14.3M
-19.10%-12.3M
-29.85%-12.15M
-44.25%-46.52M
-27.78%-14.63M
Net income from continuing operations
30.60%-12.72M
28.41%-13.36M
12.20%-14.78M
-7.17%-67.88M
18.95%-14.06M
-13.10%-18.33M
-16.90%-18.66M
-21.72%-16.83M
-19.32%-63.34M
-30.34%-17.34M
Depreciation and amortization
18.81%259K
34.92%255K
31.91%248K
50.00%822K
30.46%227K
54.61%218K
54.92%189K
69.37%188K
10.26%548K
53.98%174K
Other non cash items
187.11%913K
-50.63%157K
37.11%436K
51.37%1.27M
8.50%319K
38.26%318K
98.75%318K
102.55%318K
671.56%841K
29,300.00%294K
Change In working capital
24.07%-656K
-93.56%81K
155.04%1.16M
-520.43%-2.14M
-85.37%-2.99M
-56.24%-864K
-8.84%1.26M
-64.79%456K
114.84%509K
-13.43%-1.61M
-Change in prepaid assets
9.94%-834K
24.26%676K
57.91%499K
-44.16%282K
-44.05%348K
36.01%-926K
-10.67%544K
-56.17%316K
125.57%505K
29.58%622K
-Change in payables and accrued expense
34.89%433K
-150.82%-496K
161.15%1.04M
-247.79%-1.14M
-41.62%-2.83M
-70.95%321K
4.83%976K
-45.42%399K
-39.19%768K
-5.10%-2M
-Change in other current assets
----
----
----
---245K
----
----
----
----
--0
----
-Change in other current liabilities
-230.12%-855K
62.21%-99K
-45.95%-378K
-36.39%-1.04M
-11.02%-262K
-22.75%-259K
-63.75%-262K
-64.97%-259K
---764K
---236K
Cash from discontinued investing activities
Operating cash flow
41.20%-8.41M
26.60%-9.03M
22.64%-9.4M
-10.15%-51.24M
14.70%-12.48M
-17.26%-14.3M
-19.10%-12.3M
-29.85%-12.15M
-44.25%-46.52M
-27.78%-14.63M
Investing cash flow
Cash flow from continuing investing activities
-95.98%469K
727.00%6.53M
149.67%10.29M
141.22%29.86M
3,004.60%13.27M
116.36%11.67M
308.18%789K
1,723.23%4.12M
-14,215.42%-72.44M
-68.63%-457K
Net PPE purchase and sale
73.90%-125K
71.94%-94K
92.74%-18K
24.09%-1.23M
68.49%-167K
-5.04%-479K
11.61%-335K
2.36%-248K
-219.96%-1.62M
-95.57%-530K
Net investment purchase and sale
-95.11%594K
488.88%6.62M
135.92%10.31M
143.90%31.09M
18,312.33%13.44M
117.14%12.15M
--1.12M
--4.37M
---70.82M
--73K
Cash from discontinued investing activities
Investing cash flow
-95.98%469K
727.00%6.53M
149.67%10.29M
141.22%29.86M
3,004.60%13.27M
116.36%11.67M
308.18%789K
1,723.23%4.12M
-14,215.42%-72.44M
-68.63%-457K
Financing cash flow
Cash flow from continuing financing activities
15,622.45%7.7M
76.25%141K
1,412.50%121K
-99.20%233K
-99.35%96K
-99.65%49K
63.27%80K
8K
-62.40%29.01M
2,709.47%14.87M
Net issuance payments of debt
----
----
----
--0
--0
----
----
----
1,138.41%29.57M
--14.9M
Proceeds from stock option exercised by employees
8.97%85K
85.39%165K
-8.33%121K
24.61%395K
-21.95%96K
-46.21%78K
81.63%89K
--132K
1,119.23%317K
--123K
Net other financing activities
51.72%-14K
----
----
81.72%-162K
--0
---29K
---9K
---124K
---886K
---152K
Cash from discontinued financing activities
Financing cash flow
15,622.45%7.7M
76.25%141K
1,412.50%121K
-99.20%233K
-99.35%96K
-99.65%49K
63.27%80K
--8K
-62.40%29.01M
2,709.47%14.87M
Net cash flow
Beginning cash position
-37.73%5.01M
-62.14%7.38M
-76.86%6.36M
-76.58%27.51M
-80.26%5.47M
-91.71%8.05M
-81.93%19.48M
-76.58%27.51M
60.77%117.45M
-78.64%27.72M
Current changes in cash
90.81%-237K
79.33%-2.36M
112.63%1.01M
76.49%-21.14M
520.75%892K
96.29%-2.58M
-7.26%-11.43M
16.55%-8.02M
-302.60%-89.95M
98.28%-212K
End cash Position
-12.70%4.78M
-37.73%5.01M
-62.14%7.38M
-76.86%6.36M
-76.86%6.36M
-80.26%5.47M
-91.71%8.05M
-81.93%19.48M
-76.58%27.51M
-76.58%27.51M
Free cash flow
42.26%-8.54M
27.80%-9.12M
24.04%-9.42M
-9.00%-52.47M
16.58%-12.65M
-16.82%-14.78M
-18.02%-12.64M
-29.00%-12.4M
-46.97%-48.13M
-29.34%-15.16M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 41.20%-8.41M26.60%-9.03M22.64%-9.4M-10.15%-51.24M14.70%-12.48M-17.26%-14.3M-19.10%-12.3M-29.85%-12.15M-44.25%-46.52M-27.78%-14.63M
Net income from continuing operations 30.60%-12.72M28.41%-13.36M12.20%-14.78M-7.17%-67.88M18.95%-14.06M-13.10%-18.33M-16.90%-18.66M-21.72%-16.83M-19.32%-63.34M-30.34%-17.34M
Depreciation and amortization 18.81%259K34.92%255K31.91%248K50.00%822K30.46%227K54.61%218K54.92%189K69.37%188K10.26%548K53.98%174K
Other non cash items 187.11%913K-50.63%157K37.11%436K51.37%1.27M8.50%319K38.26%318K98.75%318K102.55%318K671.56%841K29,300.00%294K
Change In working capital 24.07%-656K-93.56%81K155.04%1.16M-520.43%-2.14M-85.37%-2.99M-56.24%-864K-8.84%1.26M-64.79%456K114.84%509K-13.43%-1.61M
-Change in prepaid assets 9.94%-834K24.26%676K57.91%499K-44.16%282K-44.05%348K36.01%-926K-10.67%544K-56.17%316K125.57%505K29.58%622K
-Change in payables and accrued expense 34.89%433K-150.82%-496K161.15%1.04M-247.79%-1.14M-41.62%-2.83M-70.95%321K4.83%976K-45.42%399K-39.19%768K-5.10%-2M
-Change in other current assets ---------------245K------------------0----
-Change in other current liabilities -230.12%-855K62.21%-99K-45.95%-378K-36.39%-1.04M-11.02%-262K-22.75%-259K-63.75%-262K-64.97%-259K---764K---236K
Cash from discontinued investing activities
Operating cash flow 41.20%-8.41M26.60%-9.03M22.64%-9.4M-10.15%-51.24M14.70%-12.48M-17.26%-14.3M-19.10%-12.3M-29.85%-12.15M-44.25%-46.52M-27.78%-14.63M
Investing cash flow
Cash flow from continuing investing activities -95.98%469K727.00%6.53M149.67%10.29M141.22%29.86M3,004.60%13.27M116.36%11.67M308.18%789K1,723.23%4.12M-14,215.42%-72.44M-68.63%-457K
Net PPE purchase and sale 73.90%-125K71.94%-94K92.74%-18K24.09%-1.23M68.49%-167K-5.04%-479K11.61%-335K2.36%-248K-219.96%-1.62M-95.57%-530K
Net investment purchase and sale -95.11%594K488.88%6.62M135.92%10.31M143.90%31.09M18,312.33%13.44M117.14%12.15M--1.12M--4.37M---70.82M--73K
Cash from discontinued investing activities
Investing cash flow -95.98%469K727.00%6.53M149.67%10.29M141.22%29.86M3,004.60%13.27M116.36%11.67M308.18%789K1,723.23%4.12M-14,215.42%-72.44M-68.63%-457K
Financing cash flow
Cash flow from continuing financing activities 15,622.45%7.7M76.25%141K1,412.50%121K-99.20%233K-99.35%96K-99.65%49K63.27%80K8K-62.40%29.01M2,709.47%14.87M
Net issuance payments of debt --------------0--0------------1,138.41%29.57M--14.9M
Proceeds from stock option exercised by employees 8.97%85K85.39%165K-8.33%121K24.61%395K-21.95%96K-46.21%78K81.63%89K--132K1,119.23%317K--123K
Net other financing activities 51.72%-14K--------81.72%-162K--0---29K---9K---124K---886K---152K
Cash from discontinued financing activities
Financing cash flow 15,622.45%7.7M76.25%141K1,412.50%121K-99.20%233K-99.35%96K-99.65%49K63.27%80K--8K-62.40%29.01M2,709.47%14.87M
Net cash flow
Beginning cash position -37.73%5.01M-62.14%7.38M-76.86%6.36M-76.58%27.51M-80.26%5.47M-91.71%8.05M-81.93%19.48M-76.58%27.51M60.77%117.45M-78.64%27.72M
Current changes in cash 90.81%-237K79.33%-2.36M112.63%1.01M76.49%-21.14M520.75%892K96.29%-2.58M-7.26%-11.43M16.55%-8.02M-302.60%-89.95M98.28%-212K
End cash Position -12.70%4.78M-37.73%5.01M-62.14%7.38M-76.86%6.36M-76.86%6.36M-80.26%5.47M-91.71%8.05M-81.93%19.48M-76.58%27.51M-76.58%27.51M
Free cash flow 42.26%-8.54M27.80%-9.12M24.04%-9.42M-9.00%-52.47M16.58%-12.65M-16.82%-14.78M-18.02%-12.64M-29.00%-12.4M-46.97%-48.13M-29.34%-15.16M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data